DUPILUMAB

Easing the Management of Atopic Dermatitis
Atopic DermatitisDr. Friedman, jack of many trades, Professor and Interim Chair of Dermatology at George Washington University provided an excellent overview of ways to achieve victory over atopic dermatitis (AD). This expert discussion took place during the ODAC Inflammatory Diseases Symposium on December 3, 2020. How could we possibly cover atopic dermatitis in 20 minutes? Well, Dr. Friedman skillfully led us …
Atopic Dermatitis
Keloid Treatment in Skin of Color: New Techniques & Pearls from the Experts
Keloid in SOCDepending on your comfort level with treating scars, you may feel hesitation when taking on treatment for patients with keloids – especially those with skin of color.  We all know keloids are more common in skin of color and we have most likely all treated these patients.  But how can we improve patient outcomes and limit side effects? During the 2020 Skin of Color Update, Drs. Maritza Pere …
Keloid in SOC
Journal Review Series: April-June 2019
Journal Review SeriesNext Steps in Derm author, Dr. Anna Chacon, searched the journals so that you don’t have to! She reports on important take-aways from different dermatology journals for the months of April, May, and June of 2019. It is key to keep in mind that “important” is subjective and what is contained in this review is one person’s view of what should be remembered from these months of the literat …
Journal Review Series
Controversies in Pediatric Dermatology: Systemic Therapies
Controversies in Pediatric DermatologyDr. Yasmine Kirkorian, Interim Chief of Dermatology at Children's National Health System and Assistant Professor of Dermatology and Pediatrics at the George Washington School of Medicine & Health Sciences, summarizes recent controversies in the field of pediatric dermatology regarding the usage of systemic therapies in children. This article will provide an overview of the following: …
Controversies in Pediatric Dermatology
JDD October Issue Highlights
Here are the issue highlights for the October issue of JDD! Characterizing how AD patients are currently treated may build a reference for future clinical research in Prescribing Patterns for Atopic Dermatitis in the United States.  A Global Review on the Risk Factors and Management of Early Atopic Dermatitis in Children Ages 0 to 2 Years Old explores early intervention in infants and you …